Emergence of resistant tinea corporis in a low socioeconomic setting
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf551 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Harshani Thabrew und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka. Hauptthemen laut MEDLINE: Tinea, Antifungal Agents, Drug Resistance, Fungal, Arthrodermataceae. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background
Treatment resistance in tinea corporis has emerged recently, resulting in unresponsive infections.
Objectives
To assess the resistance of recalcitrant dermatophytoses on glabrous skin and to understand the situation in Sri Lanka.
Methods
A descriptive, observational, cross-sectional study was conducted involving nine hospitals representing all nine provinces in Sri Lanka over 6 months, starting from June 2019. All patients with dermatophyte infections in the glabrous skin were included. Sociodemographic characteristics, symptoms and prior treatment were collected. Antifungal sensitivity testing was done by a method adopted from EUCAST E.DEF 9.3 (2015). Quality control was done to ensure the accuracy of results.
Results
The study included 127 isolates of dermatophytes for testing antifungal sensitivity. Trichophyton mentagrophytes comprised the majority, with 79 isolates, while there were 48 isolates of T. rubrum. The mean minimum inhibitory concentration (50th percentile; MIC50) of terbinafine was 0.064 g mL–1 for T. mentagrophytes. A significant number of isolates (8 of 32, 25%) had an MIC higher than the epidemiological cutoff of 0.125 g mL–1 set by EUCAST for terbinafine, indicating a higher likelihood of clinical failure. The MIC50 for itraconazole was 0.25 g mL–1. Considering the epidemiological cutoff of 0.25 g mL–1 for T. mentagrophytes, 33 of 79 (42%) isolates tested for itraconazole were higher.
Conclusions
Itraconazole may need to be used in the treatment, with close monitoring of the response of the patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka.
- Department of Dermatology, Colombo East Base Hospital, Mulleriyawa, Sri Lanka.
- Department of Dermatology, Base Hospital, Nawalapitiya, Sri Lanka.
- Department of Community Medicine, Faculty of Medicine, University of Colombo, Sri Lanka.
- Office for Mycology and Tropical Dermatology, Basselweg, Germany.
- Department of Mycology, Medical Research Institute, Colombo 8, Sri Lanka.
ORCID-Profile: Harshani Thabrew
Zitieren
APA
Thabrew, H., Madarasinghe, N., Eriyagama, S., Weliange, S., Reinel, D., & Jayasekera, P. (2025). Emergence of resistant tinea corporis in a low socioeconomic setting. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf551
Vancouver
Thabrew H, Madarasinghe N, Eriyagama S, Weliange S, Reinel D, Jayasekera P. Emergence of resistant tinea corporis in a low socioeconomic setting. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf551
BibTeX
@article{Thabrew2025,
author = {Thabrew, Harshani and Madarasinghe, Nayani and Eriyagama, Surammika and Weliange, Shreenika and Reinel, Dieter and Jayasekera, Primali},
title = {Emergence of resistant tinea corporis in a low socioeconomic setting},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf551}
}
EUVIMED